Can the regulatory response to SUPPORT be supported?
作者信息
Hunter David
机构信息
a Flinders University.
出版信息
Am J Bioeth. 2013;13(12):37-9. doi: 10.1080/15265161.2013.849305.
PMID:24256534
Abstract
摘要
相似文献
1
Can the regulatory response to SUPPORT be supported?对“SUPPORT”的监管回应能得到支持吗？
Am J Bioeth. 2013;13(12):37-9. doi: 10.1080/15265161.2013.849305.
2
SUPPORT asked the wrong question.SUPPORT问了错误的问题。
Am J Bioeth. 2013;13(12):25-6. doi: 10.1080/15265161.2013.851300.
3
Informed consent is not the major ethical issue in clinical research.知情同意并非临床研究中的主要伦理问题。
Am J Bioeth. 2013;13(12):24. doi: 10.1080/15265161.2013.851571.
4
Community engagement: critical to continued public trust in research.社区参与：对公众持续信任研究至关重要。
Am J Bioeth. 2013;13(12):44-6. doi: 10.1080/15265161.2013.851296.
5
Quality improvement ethics: lessons from the SUPPORT study.质量改进伦理学：来自 SUPPORT 研究的经验教训。
Am J Bioeth. 2013;13(12):14-9. doi: 10.1080/15265161.2013.851582.
6
Risk, respect for persons, and informed consent in comparative effectiveness research.比较效果研究中的风险、对人的尊重与知情同意
Am J Bioeth. 2013;13(12):46-8. doi: 10.1080/15265161.2013.851299.
7
The weird divergence of ethics and regulation with regard to informed consent.在知情同意方面，伦理与监管出现了奇怪的分歧。
Am J Bioeth. 2013;13(12):31-3. doi: 10.1080/15265161.2013.849308.
8
The "research misconception" and the SUPPORT trial: toward evidence-based consensus.“研究误区”与SUPPORT试验：迈向基于证据的共识
Am J Bioeth. 2013;13(12):48-50. doi: 10.1080/15265161.2013.851297.
9
Randomization should be disclosed to potential research subjects.随机化过程应向潜在的研究对象公开。
Am J Bioeth. 2013;13(12):35-7. doi: 10.1080/15265161.2013.849307.
10
What are reasonably foreseeable risks?哪些是合理可预见的风险？
Am J Bioeth. 2013;13(12):29-30. doi: 10.1080/15265161.2013.849304.
引用本文的文献
1
The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.实用临床试验设计和实施中引发的伦理挑战：关键利益攸关方的访谈研究。
Trials. 2019 Dec 23;20(1):765. doi: 10.1186/s13063-019-3899-x.
Zotero 插件